Form 4 for NRSN NeuroSense Therapeutics Ltd.
Accepted 2026-06-17 16:30:02 ET · period of report 2026-06-16 · accession 0001213900-26-069663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 16:30 | 2026-06-16 | NRSN | Ben-Noon Alon | CEO | P - Purchase | $0.8 | +250.0K | 4.53M | +6% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-16 | P | A | 250,000 | $0.8 | 4,534,233 | D | — | — | (F1) On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. |